NON SMALL CELL LUNG CARCINOMA NSCLC
Clinical trials for NON SMALL CELL LUNG CARCINOMA NSCLC explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CARCINOMA NSCLC trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CARCINOMA NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug SCTB14 takes on standard immunotherapy in lung cancer showdown
Disease control Recruiting nowThis phase 3 trial compares a new experimental drug, SCTB14, to the standard immunotherapy pembrolizumab (Keytruda) as a first treatment for people with advanced non-small cell lung cancer whose tumors have high PD-L1 levels (TPS ≥10%). About 246 participants will receive either …
Matched conditions: NON SMALL CELL LUNG CARCINOMA NSCLC
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Lung cancer study questions if lower chemo doses harm older patients
Knowledge-focused Recruiting nowThis study looks at whether giving older lung cancer patients a lower dose of chemotherapy affects how long they live. Researchers will compare survival between patients who got standard doses and those who got reduced doses. The goal is to understand if dose reductions are safe …
Matched conditions: NON SMALL CELL LUNG CARCINOMA NSCLC
Sponsor: University of Malaya • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC